Skip to main content
Publish date:

Boston Scientific negotiating to buy three Israeli med-tech firms for $100m

All target companies make minimally invasive medical systems

Boston Scientific (NYSE:BSX) is negotiating to buy three Israeli companies for $100 million, says the medical-technology company's CFO, Larry Best, according to Ma'ariv.

All the Israeli companies in question develop minimally-invasive medical applications.

Boston is meanwhile embroiled in a legal battle with another Israeli firm, the stent-maker Medinol. Entering into partnership with Medinol was the worst mistake Boston ever made, Best said. But he also added that the situation with Medinol is of no importance.

TheStreet Recommends